A team of biomolecular engineers, pathologists, and internal medicine specialists at the University of Texas Medical Branch, ...

A new study shows how an anticancer drug triggers an "outside in" signal that gets it sucked into a cancer cell. The work, published Jan. 29 in Nature Communications, reveals a new signaling mechanism ...

Antigen processing and presentation is the mechanism by which whole antigens are degraded and loaded onto MHC molecules for display on the cell surface for recognition by T cells. Both macrophages ...

Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to ITM), announced ...

Further Capital to Assist with Increasing Capabilities, Capacity, and EfficiencyMISSISSAUGA, Ontario, Feb. 04, 2025 (GLOBE ...

Acquisition to strengthen key pillar of BioNTech's oncology strategy aimed at establishing BNT327 as a pan-tumor technology platform for the treatment of advanced cancersWith the closing of the transa ...

By reducing failure rates early, OptiMAL helps pharma companies de-risk investments, making Fusion Antibodies a high-value solution provider. • A faster drug development cycle means more pharma ...

In the update announcement post, Google explains that Gemini in Sheets is now better at identifying trends and relationships between variables, generating charts to be inserted into spreadsheets ...

Anybody who’s had to grapple with turning a spreadsheet jam-packed with raw data into a killer chart or graph will rejoice at a new update Google has made to its Gemini AI tool. The company says ...

Amgen (NASDAQ:AMGN) today announced financial results for the fourth quarter and full year of 2024 versus comparable ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...